[go: up one dir, main page]

ATE316779T1 - Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung - Google Patents

Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung

Info

Publication number
ATE316779T1
ATE316779T1 AT98930779T AT98930779T ATE316779T1 AT E316779 T1 ATE316779 T1 AT E316779T1 AT 98930779 T AT98930779 T AT 98930779T AT 98930779 T AT98930779 T AT 98930779T AT E316779 T1 ATE316779 T1 AT E316779T1
Authority
AT
Austria
Prior art keywords
production
controlled release
implants
core
active ingredients
Prior art date
Application number
AT98930779T
Other languages
English (en)
Inventor
Alexandra Rothen-Weinhold
Robert Gurny
Piero Orsolini
Frederic Heimgartner
Original Assignee
Debio Rech Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debio Rech Pharma Sa filed Critical Debio Rech Pharma Sa
Application granted granted Critical
Publication of ATE316779T1 publication Critical patent/ATE316779T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98930779T 1997-06-04 1998-06-02 Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung ATE316779T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9706874 1997-06-04

Publications (1)

Publication Number Publication Date
ATE316779T1 true ATE316779T1 (de) 2006-02-15

Family

ID=9507573

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98930779T ATE316779T1 (de) 1997-06-04 1998-06-02 Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung

Country Status (10)

Country Link
US (1) US6319512B1 (de)
EP (1) EP1001743B1 (de)
JP (1) JP2002511075A (de)
AT (1) ATE316779T1 (de)
AU (1) AU742372B2 (de)
CA (1) CA2291659A1 (de)
DE (1) DE69833375D1 (de)
IL (1) IL133105A (de)
NO (1) NO995908L (de)
WO (1) WO1998055101A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6767550B1 (en) * 2000-06-30 2004-07-27 Berkeley Advanced Biomaterials, Inc. Hydroxyapatite based drug delivery implant for cancer treatment
CA2423431A1 (en) * 2000-10-06 2002-04-11 Durect Corporation Devices and methods for management of inflammation
US7666445B2 (en) * 2000-10-20 2010-02-23 The Trustees Of The University Of Pennsylvania Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
WO2003000156A1 (en) 2001-06-22 2003-01-03 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
JP2005503389A (ja) * 2001-08-31 2005-02-03 シエーリング オサケユイチア 薬物送達システム
DE10237572A1 (de) * 2002-08-13 2004-02-26 Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin Stent mit polymerer Beschichtung
SE0202619D0 (sv) * 2002-09-05 2002-09-05 Fredrik Nederberg New Polymers and Applications
CA2553254C (en) * 2004-01-12 2013-12-17 The Trustees Of The University Of Pennsylvania Long-term delivery formulations and methods of use thereof
US8329203B2 (en) * 2004-01-12 2012-12-11 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8221778B2 (en) 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8119154B2 (en) * 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
WO2005107715A1 (en) * 2004-05-11 2005-11-17 Debio Recherche Pharmaceutique S.A. Implantable composition
WO2006078320A2 (en) 2004-08-04 2006-07-27 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
CN103637977A (zh) * 2005-07-18 2014-03-19 宾夕法尼亚大学理事会 含药植入物及其使用方法
AR058591A1 (es) * 2005-12-22 2008-02-13 Novartis Ag Formulacion de liberacion sostenida que comprende octreotida y dos o mas polimeros de polilactido-coglicolido
PL2010184T3 (pl) * 2006-04-06 2013-07-31 Nupathe Inc Implanty do leczenia stawów związanych z dopaminą
EP2018151A4 (de) * 2006-05-09 2012-07-18 Astrazeneca Ab Im endbehältnis mittels ionisierender strahlung sterilisierte parenterale formulierung mit protonenpumpenhemmer
ITMI20061538A1 (it) * 2006-08-02 2008-02-03 Mediolanum Pharmaceuticals Ltd Impianti sottocutanei in grado di rilasciare il principio attivo per un periodo prolungato di tempo
US8728528B2 (en) 2007-12-20 2014-05-20 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
WO2010088697A2 (en) * 2009-02-02 2010-08-05 Medtronic, Inc. Antimicrobial accessory for an implantable medical device
EP2246063A1 (de) 2009-04-29 2010-11-03 Ipsen Pharma S.A.S. GnRH Analoge enthaltende Retardformulierungen
US20100278895A1 (en) * 2009-04-30 2010-11-04 Medtronic, Inc. Antioxidants and antimicrobial accessories including antioxidants
BR112012002341A8 (pt) 2009-08-06 2017-10-10 Koninklijke Philips Electronics Nv Semente radioativa para uso na terapia oncológica e método de terapia oncológica
IN2012DN02656A (de) * 2009-09-17 2015-09-11 Evonik Degussa Corp
US8911427B2 (en) * 2010-12-28 2014-12-16 Medtronic, Inc. Therapeutic agent reservoir delivery system
US12403291B2 (en) 2019-08-30 2025-09-02 Intersect Ent, Inc. Submucosal bioresorbable drug eluting platform

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2041377B (en) * 1979-01-22 1983-09-28 Woodroof Lab Inc Bio compatible and blood compatible materials and methods
DE3684446D1 (de) * 1985-12-28 1992-04-23 Sumitomo Pharma Arzneimittel mit verzoegerter stossweiser freisetzung.
US4894231A (en) 1987-07-28 1990-01-16 Biomeasure, Inc. Therapeutic agent delivery system
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
AU651084B2 (en) * 1990-01-30 1994-07-14 Akzo N.V. Article for the controlled delivery of an active substance, comprising a hollow space fully enclosed by a wall and filled in full or in part with one or more active substances
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
WO1994003159A1 (en) * 1992-07-31 1994-02-17 Daratech Pty. Ltd. Controlled release implants
JP3720386B2 (ja) * 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
AUPM897594A0 (en) * 1994-10-25 1994-11-17 Daratech Pty Ltd Controlled release container
DE69731902T2 (de) * 1996-02-02 2005-12-22 Alza Corp., Mountain View Implantierbares System mit verzögerter Wirkstofffreisetzung

Also Published As

Publication number Publication date
NO995908D0 (no) 1999-12-02
AU8109398A (en) 1998-12-21
IL133105A0 (en) 2001-03-19
AU742372B2 (en) 2002-01-03
EP1001743A1 (de) 2000-05-24
IL133105A (en) 2004-09-27
EP1001743B1 (de) 2006-02-01
CA2291659A1 (fr) 1998-12-10
WO1998055101A1 (fr) 1998-12-10
NO995908L (no) 1999-12-02
US6319512B1 (en) 2001-11-20
JP2002511075A (ja) 2002-04-09
DE69833375D1 (de) 2006-04-13

Similar Documents

Publication Publication Date Title
ATE316779T1 (de) Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung
ATE237285T1 (de) Medizinisches implantat
CA2158638A1 (en) A Composition and a Method for Tissue Augmentation
CA2235919A1 (en) Non-polymeric sustained release delivery system
NO303425B1 (no) FremgangsmÕte for behandling av et kirurgisk metallimplantat
ATE198982T1 (de) Verfahren zur herstellung von festen pharmazeutischen dosierungsformen hydrophobischen substanzen
ATE243720T1 (de) Hydrogelbildende, selbst-solvatisierende, absorbierbare polyestercopolymere sowie verfahren zu deren verwendung
PT88945A (pt) Processo para a preparacao de formas de dosagem farmaceuticas de libertacao controlada contendo um antagonista do calcio, tal como cloridrato de diltiazem
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
HUP0302630A2 (hu) Eljárás gyógyszerek sterilizálására
JPH08508655A (ja) 診療および外科学に使用し得る半合成材料
NO995843D0 (no) Farmasöytisk preparat omfattende vWF-propeptid
DE3682811D1 (de) Pharmazeutische zusammensetzung zur heilung und verhuetung kardiovaskularer krankheiten und verfahren zu ihrer herstellung.
DE59611383D1 (de) Darreichungsform zur applikation von pharmazeutischen wirkstoffen und hilfsstoffen und verfahren zur herstellung derselben
FR2845289B1 (fr) Spheroides, procede de preparation et compositions pharmaceutiques.
DE69719930D1 (de) Verfahren zur Herstellung von medizinischen Pflastern zur perkutanen Verabreichung, und Vorrichtung dafür
RU94013093A (ru) Способ хирургического лечения аневризм восходящей аорты
DE69804766D1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DE69410042D1 (de) Esterverbindung, Wirkstoff zur Kontrolle von schädlichen Parasiten diese enthaltend als Wirksubstanz, Zwischenverbindung zur Herstellung der Esterverbindung, sowie Verfahren zur Herstellung der Zwischenverbindung
AP9801416A0 (en) Method Of treating a plant disease.
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
DE69733321D1 (de) Olanzapine zur behandlung von drogenmissbrauch
NO952912D0 (no) En ny osteoblastisk proliferativ faktor
FR2736548B1 (fr) Utilisation d'un retinoide pour la preparation d'un medicament antibacterien et methode de traitement cosmetique

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties